Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Squire

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Cancer Research|November 5, 2002
Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosisAlison M Y Cheung, M Prakash Hande, Farid Jalali, et al.
Genes & Development|September 23, 2008
TAp73 knockout shows genomic instability with infertility and tumor suppressor functionsRichard Tomasini, Katsuya Tsuchihara, Margareta Wilhelm, et al.
The New England Journal of Medicine|July 15, 2005
Erlotinib in lung cancer - molecular and clinical predictors of outcomeMing-Sound Tsao, Akira Sakurada, Jean-Claude Cutz, et al.
The Journal of Clinical Investigation|August 11, 2010
Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in miceSam D Molyneux, Marco A Di Grappa, Alexander G Beristain, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repairAlan Dal Pra, Emilie Lalonde, Jenna Sykes, et al.
The Journal of Molecular Diagnostics : JMD|April 9, 2013
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyNeal I Lindeman, Philip T Cagle, Mary Beth Beasley, et al.
Plos Genetics|November 30, 2011
Role of Pirh2 in mediating the regulation of p53 and c-MycAnne Hakem, Miyuki Bohgaki, Bénédicte Lemmers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancer Research|November 5, 2002
Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosisAlison M Y Cheung, M Prakash Hande, Farid Jalali, et al.
Genes & Development|September 23, 2008
TAp73 knockout shows genomic instability with infertility and tumor suppressor functionsRichard Tomasini, Katsuya Tsuchihara, Margareta Wilhelm, et al.
The New England Journal of Medicine|July 15, 2005
Erlotinib in lung cancer - molecular and clinical predictors of outcomeMing-Sound Tsao, Akira Sakurada, Jean-Claude Cutz, et al.
The Journal of Clinical Investigation|August 11, 2010
Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in miceSam D Molyneux, Marco A Di Grappa, Alexander G Beristain, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repairAlan Dal Pra, Emilie Lalonde, Jenna Sykes, et al.
The Journal of Molecular Diagnostics : JMD|April 9, 2013
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyNeal I Lindeman, Philip T Cagle, Mary Beth Beasley, et al.
Plos Genetics|November 30, 2011
Role of Pirh2 in mediating the regulation of p53 and c-MycAnne Hakem, Miyuki Bohgaki, Bénédicte Lemmers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Pageof 4